Insider · CIK 0001289557
Daniel R Chard
Files at MED (MEDIFAST INC). First filing Jun 17, 2025, latest Sep 30, 2026.
In brief
Daniel R Chard files SEC Form 4 as CEO, chair and director at MED (MEDIFAST INC). Since Jun 17, 2025, Daniel R Chard has reported 2 open-market buys worth $184k and 1 open-market sell worth $226k, the latest filed on Sep 30, 2026.
A track record needs three past buys with six months of prices behind them; Daniel R Chard has 0, so none is measured yet.
The newest scored trade: sold $226k of MED on Sep 28, 2026, filed Sep 30, 2026, scored 13 (weak), under a 10b5-1 plan. In the last 12 months: 1 buy worth $179k and 1 sell worth $226k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MED: MEDIFAST INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | MEDIFAST INC | $226k 19,089 shares | -13% | - | |
| 63Notable | MEDbuy MEDIFAST INC | $179k 17,678 shares | - | +5% from low-34% from high | |
| 38Weak | MEDbuy MEDIFAST INC | $5,003 381 shares | +0% | +9% from low-40% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 29, 2026 | MED MEDIFAST INC | 9,544 0.09% of outstanding | $112k | Sep 29, 2026 | $114k |
| Sep 28, 2026 | MED MEDIFAST INC | 9,545 0.09% of outstanding | $114k | Sep 28, 2026 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | MED MEDIFAST INC | SOpen-market sale Common Stockindirect: The Dan and Allyson Family Irrevocable Trust10b5-1 | -9,545 | $11.98 | $114k | 140,153 | 13 d ago |
| Sep 29, 2026 | MED MEDIFAST INC | SOpen-market sale Common Stockindirect: The Dan and Allyson Family Irrevocable Trust10b5-1 | -9,544 | $11.73 | $112k | 130,609 | 13 d ago |
| Mar 13, 2026 | MED MEDIFAST INC | FTax withholding Common Stock | -7,075 | $9.62 | $68k | 169,171 | Mar 27, 2026 |
| Mar 17, 2026 | MED MEDIFAST INC | FTax withholding Common Stock | -2,638 | $10.05 | $27k | 166,533 | Mar 27, 2026 |
| Mar 20, 2026 | MED MEDIFAST INC | POpen-market purchase Common Stockindirect: Dan and Allyson as Joint Tenants | +17,678 | $10.11 | $179k | 17,678 | Mar 27, 2026 |
| Mar 25, 2026 | MED MEDIFAST INC | FTax withholding Common Stock | -20,095 | $9.59 | $193k | 146,438 | Mar 27, 2026 |
| Mar 25, 2026 | MED MEDIFAST INC | AGrant or award Common Stock | +36,968 | $0.00 | $0 | 183,406 | Mar 27, 2026 |
| Mar 25, 2026 | MED MEDIFAST INC | AGrant or award Common Stock | +4,827 | $0.00 | $0 | 188,233 | Mar 27, 2026 |
| Jun 13, 2025 | MED MEDIFAST INC | POpen-market purchase Common Stockindirect: The Dan and Allyson Family Irrevocable Trust | +381 | $13.13 | $5,003 | 149,698 | Jun 17, 2025 |
| Mar 25, 2025 | MED MEDIFAST INC | AGrant or award Common Stock | +124,953 | $0.00 | $0 | 176,246 | Mar 27, 2025 |
| Mar 13, 2025 | MED MEDIFAST INC | FTax withholding Common Stock | -5,001 | $13.87 | $69k | 54,101 | Mar 18, 2025 |
| Mar 16, 2025 | MED MEDIFAST INC | FTax withholding Common Stock | -944 | $13.94 | $13k | 53,157 | Mar 18, 2025 |
| Mar 17, 2025 | MED MEDIFAST INC | FTax withholding Common Stock | -1,864 | $14.35 | $27k | 51,293 | Mar 18, 2025 |
Questions about Daniel R Chard
Answered from the filings on this page, as of the latest one.
Is Daniel R Chard buying or selling?
In the last 12 months Daniel R Chard reported 1 open-market buy worth $179k and 1 open-market sell worth $226k on SEC Form 4; the latest was sold $226k of MED on Sep 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Daniel R Chard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel R Chard has 0.
Where does Daniel R Chard file Form 4?
Daniel R Chard has filed Form 4 at MED (MEDIFAST INC) as Chairman & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.